Publication Name	World Journal of Clinical Cases
Manuscript ID	84172
Country	China

Received	2023-03-02 14:37
Peer-Review Started	2023-03-02 14:39
To Make the First Decision
Return for Revision	2023-03-24 02:00
Revised	2023-04-02 11:18
Second Decision	2023-04-07 01:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-04-07 07:55
Articles in Press	2023-04-07 07:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-05-04 06:06
Publish the Manuscript Online	2023-05-16 09:24

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Bladder metastasis from EGFR mutant lung cancer: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Cai-Bao Jin and Ling Yang
ORCID	Author(s) ORCID Number Cai-Bao Jin http://orcid.org/0000-0003-3544-5774 Ling Yang http://orcid.org/0000-0002-5914-9614
Funding Agency and Grant Number
Corresponding Author	Ling Yang, MD, Chief Doctor, Department of Thoracic Oncology, Hubei Cancer Hospital, No. 116 Zhuodaoquan South Road, Wuhan 430000, Hubei Province, China. 348711624@qq.com
Key Words	Bladder metastasis; Lung cancer; EGFR mutation; Tyrosine kinase inhibitor; Histological examination; Case report
Core Tip	Bladder metastasis from lung cancer with epidermal growth factor receptor (EGFR) mutation is extremely rare. We reported a case of bladder metastasis from lung adenocarcinoma with EGFR mutation. During routine follow-up of lung cancer patients, imaging examination of the pelvic cavity should be performed to avoid missing bladder metastasis. The ultimate diagnosis of bladder metastasis sill depends on the pathological result of biopsy tissues as determined by cystoscopy. Bladder metastasis with EGFR mutation seems to respond well to the treatment of EGFR tyrosine kinase inhibitors.
Publish Date	2023-05-16 09:24
Citation	Jin CB, Yang L. Bladder metastasis from EGFR mutant lung cancer: A case report. World J Clin Cases 2023; 11(14): 3356-3361
URL	https://www.wjgnet.com/2307-8960/full/v11/i14/3356.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i14.3356

Full Article (PDF)	WJCC-11-3356.pdf
Full Article (Word)	WJCC-11-3356.docx
CARE Checklist–2016	84172-CARE-Checklist–2016-revision.pdf
Manuscript File	84172_Auto_Edited-JLW.docx
Answering Reviewers	84172-Answering reviewers.pdf
Audio Core Tip	84172-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	84172-Conflict-of-interest statement.pdf
Copyright License Agreement	84172-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	84172-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	84172-Language certificate.pdf
Peer-review Report	84172-Peer-review(s).pdf
Scientific Misconduct Check	84172-Bing-Ma YJ-2.jpg
Scientific Editor Work List	84172-Scientific editor work list.pdf